Angelia C Kirkpatrick1, Alfonso J Tafur2, Andrea S Vincent2, George L Dale2, Calin I Prodan2. 1. From the Departments of Medicine (A.C.K., A.J.T., G.L.D.) and Neurology (C.I.P.), University of Oklahoma Health Sciences Center, Oklahoma City; Cognitive Science Research Center, University of Oklahoma, Norman (A.S.V.); and Veterans Affairs Medical Center, Oklahoma City, OK (A.C.K., C.I.P.). akirkpat@ouhsc.edu. 2. From the Departments of Medicine (A.C.K., A.J.T., G.L.D.) and Neurology (C.I.P.), University of Oklahoma Health Sciences Center, Oklahoma City; Cognitive Science Research Center, University of Oklahoma, Norman (A.S.V.); and Veterans Affairs Medical Center, Oklahoma City, OK (A.C.K., C.I.P.).
Abstract
BACKGROUND AND PURPOSE: Coated-platelets, a subset of procoagulant platelets observed on dual agonist stimulation with collagen and thrombin, support a robust prothrombinase activity and provide a unique measure of platelet thrombotic potential. Coated-platelet levels are increased in large artery stroke, and higher levels are associated with early stroke recurrence, suggesting a potential role for risk stratification in asymptomatic patients with carotid artery stenosis. METHODS: Three-hundred twenty-nine consecutive patients with technically adequate carotid Doppler evaluation without stroke or transient ischemic attack (TIA) in the previous 6 months were enrolled as part of a prospective cohort study conducted during a 40-month period. The main outcome was occurrence of stroke or TIA according to coated-platelet levels and internal carotid stenosis severity at enrollment. The optimal cutoff value of coated-platelet levels was determined by recursive partitioning analysis. Event-free survival was estimated using Kaplan-Meier and Cox proportional hazards regression analyses. RESULTS: A cutoff of ≥45% for coated-platelet levels in combination with stenosis≥50% yielded a sensitivity of 0.78 (95% confidence interval, 0.51-1.0), specificity of 0.92 (0.89-0.95), positive predictive value of 0.21 (0.07-0.34), and a negative predictive value of 0.99 (0.98-1.0) for ipsilateral stroke or TIA. The incidence rate of ipsilateral stroke or TIA for patients with ≥50% stenosis and ≥45% coated-platelets was 21.5 per 100 person-years versus 1.27 per 100 person-years for patients with ≥50% stenosis and <45% coated-platelets (P<0.0001). CONCLUSIONS: Coated-platelet levels identify asymptomatic carotid stenosis patients at high risk for stroke or TIA, which suggests a role for coated-platelets in risk stratification before revascularization.
BACKGROUND AND PURPOSE: Coated-platelets, a subset of procoagulant platelets observed on dual agonist stimulation with collagen and thrombin, support a robust prothrombinase activity and provide a unique measure of platelet thrombotic potential. Coated-platelet levels are increased in large artery stroke, and higher levels are associated with early stroke recurrence, suggesting a potential role for risk stratification in asymptomatic patients with carotid artery stenosis. METHODS: Three-hundred twenty-nine consecutive patients with technically adequate carotid Doppler evaluation without stroke or transient ischemic attack (TIA) in the previous 6 months were enrolled as part of a prospective cohort study conducted during a 40-month period. The main outcome was occurrence of stroke or TIA according to coated-platelet levels and internal carotid stenosis severity at enrollment. The optimal cutoff value of coated-platelet levels was determined by recursive partitioning analysis. Event-free survival was estimated using Kaplan-Meier and Cox proportional hazards regression analyses. RESULTS: A cutoff of ≥45% for coated-platelet levels in combination with stenosis≥50% yielded a sensitivity of 0.78 (95% confidence interval, 0.51-1.0), specificity of 0.92 (0.89-0.95), positive predictive value of 0.21 (0.07-0.34), and a negative predictive value of 0.99 (0.98-1.0) for ipsilateral stroke or TIA. The incidence rate of ipsilateral stroke or TIA for patients with ≥50% stenosis and ≥45% coated-platelets was 21.5 per 100 person-years versus 1.27 per 100 person-years for patients with ≥50% stenosis and <45% coated-platelets (P<0.0001). CONCLUSIONS: Coated-platelet levels identify asymptomatic carotid stenosispatients at high risk for stroke or TIA, which suggests a role for coated-platelets in risk stratification before revascularization.
Authors: Nadine J A Mattheij; Frauke Swieringa; Tom G Mastenbroek; Michelle A Berny-Lang; Frauke May; Constance C F M J Baaten; Paola E J van der Meijden; Yvonne M C Henskens; Erik A M Beckers; Dennis P L Suylen; Marc W Nolte; Tilman M Hackeng; Owen J T McCarty; Johan W M Heemskerk; Judith M E M Cosemans Journal: Haematologica Date: 2015-12-31 Impact factor: 9.941
Authors: Stephen J Murphy; Soon T Lim; Justin A Kinsella; Sean Tierney; Bridget Egan; Tim M Feeley; Clare Dooley; James Kelly; Sinead M Murphy; Richard A Walsh; Ronan Collins; Tara Coughlan; Desmond O'Neill; Joseph A Harbison; Prakash Madhavan; Sean M O'Neill; Mary P Colgan; Jim F Meaney; George Hamilton; Dominick Jh McCabe Journal: J Cereb Blood Flow Metab Date: 2019-11-11 Impact factor: 6.200
Authors: Mohamad H Khattab; Calin I Prodan; Andrea S Vincent; Chao Xu; Kellie R Jones; Sharanjeet Thind; Meheroz Rabadi; Shubhada Mithilesh; Eleanor Mathews; Leslie Guthery; George L Dale; Angelia C Kirkpatrick Journal: Geroscience Date: 2021-06-09 Impact factor: 7.713
Authors: Alicia Veninga; Constance C F M J Baaten; Ilaria De Simone; Bibian M E Tullemans; Marijke J E Kuijpers; Johan W M Heemskerk; Paola E J van der Meijden Journal: Thromb Haemost Date: 2021-10-24 Impact factor: 6.681